Metagenomi Therapeutics Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | -257 | 1,248 | 3,911 | 8,659 | 8,513 |
| Gross Profit | -257 | 1,248 | 3,911 | 8,659 | 8,513 |
| Operating Expenses | 28,516 | 25,835 | 28,278 | 31,498 | 29,500 |
| Operating Income | -28,773 | -24,587 | -24,367 | -22,839 | -20,987 |
| Other Income | 1,291 | 1,538 | 1,873 | 2,212 | 1,123 |
| Pre-tax Income | -27,482 | -23,049 | -22,494 | -20,627 | -19,864 |
| Income Tax | N/A | 10 | 34 | -234 | 44 |
| Net Income Continuous | -27,482 | -23,059 | -22,528 | -20,393 | -19,908 |
| Net Income | $-27,482 | $-23,059 | $-22,528 | $-20,393 | $-19,908 |
| EPS Basic Total Ops | -0.73 | -0.61 | -0.59 | -0.55 | -0.54 |
| EPS Basic Continuous Ops | -0.73 | -0.61 | -0.60 | -0.55 | -0.54 |
| EPS Diluted Total Ops | -0.73 | -0.61 | -0.59 | -0.55 | -0.54 |
| EPS Diluted Continuous Ops | -0.73 | -0.61 | -0.60 | -0.55 | -0.54 |
| EPS Diluted Before Non-Recurring Items | -0.73 | -0.61 | -0.60 | -0.55 | -0.54 |
| EBITDA(a) | $-27,069 | $-23,672 | $-23,537 | $-22,345 | $-20,480 |